Stockscreener 앱 받기
2.50
5.04%
0.12
전일 마감가:
$2.38
열려 있는:
$2.38
하루 거래량:
24,455
Relative Volume:
0.38
시가총액:
$2.05M
수익:
-
순이익/손실:
$-11.66M
주가수익비율:
-0.2462
EPS:
-10.156
순현금흐름:
$-11.09M
1주 성능:
+12.10%
1개월 성능:
-21.39%
6개월 성능:
-63.45%
1년 성능:
-71.60%
1일 변동 폭
$2.3601
$2.5506
1주일 범위
$2.1678
$2.66
52주 변동 폭
$2.1678
$18.81
Phio Pharmaceuticals Corp Stock (PHIO) Company Profile
명칭
Phio Pharmaceuticals Corp
전화
(508) 767-3861
주소
11 APEX DRIVE, SUITE 300A, MARLBOROUGH, MA
PHIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| PHIO | 2.4999 | 2.05M | 0 | -11.66M | -11.09M | -10.16 |
| VRTX | 449.35 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 749.23 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 588.75 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 247.29 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.11 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-08-05 | 개시 | H.C. Wainwright | Buy |
Phio Pharmaceuticals Corp 주식(PHIO)의 최신 뉴스
Phio Pharmaceuticals Announces Completion of Enrollment in Second - The Kingston Whig-Standard
Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study - Newsfile
Phio Pharmaceuticals Corp. (PHIO) Quarterly 10-Q Report - Quartzy
Phio Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update - Alberta Daily Herald Tribune
Phio Pharmaceuticals Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
PHIO stock touches 52-week low at $2.38 amid market challenges - Investing.com
Palantir Technologies Inc Cl A (PLTR-N) QuotePress Release - The Globe and Mail
PHIOPhio Pharmaceuticals Corp. Latest Stock News & Market Updates - StockTitan
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - Newsfile
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Quantisnow
Phio Pharmaceuticals Announces Upcoming Presentation at the 39th - Shoreline Beacon
Correction to Registration Link to Access Phio Pharmaceuticals' Presentation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series - Newsfile
Financial Analysis: Dianthus Therapeutics (NASDAQ:DNTH) and Phio Pharmaceuticals (NASDAQ:PHIO) - Defense World
Nasdaq Financial 100 Index (IXF) QuotePress Release - The Globe and Mail
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-deal Roadshow Series - StockTitan
Phio Pharmaceuticals presents novel cancer therapy data - Investing.com
Phio Pharmaceuticals presents novel cancer therapy data By Investing.com - Investing.com South Africa
Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference - Newsfile
Understanding the Risks of Investing in Phio Pharmaceuticals Corp (PHIO) - Knox Daily
Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA - MSN
Phio Announces Data Showcasing INTASYL's Role in Helping Immune Cells Target and Kill Cancer Cells - Newsfile
Phio Pharmaceuticals (NASDAQ:PHIO) Shares Down 2.5% – Time to Sell? - Defense World
Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer Conference - Yahoo Finance
Nu Holdings Ltd Cl A (NU-N) QuotePress Release - The Globe and Mail
This trade activity should not be overlooked: Hyliion Holdings Corporation (HYLN) - SETE News
INTASYL Technology and Compounds to be Focus of Presentation at 20th - North Bay Nugget
INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society - Newsfile
HITE Hedge Asset Management LLC Sells 12,931 Shares of PHINIA Inc. (NYSE:PHIN) - MarketBeat
Dow Jones Industrials Average (DOWI) QuotePress Release - The Globe and Mail
Hyliion Holdings Corporation (HYLN) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 4% - MarketBeat
Financial Metrics Unveiled: P3 Health Partners Inc (PIII)’s Key Ratios in the Spotlight - The Dwinnex
Does Hyliion Holdings Corporation (NYSE: HYLN) Still Need To Convince Analysts? - Stocks Register
Barrow Hanley Mewhinney & Strauss LLC Purchases Shares of 898,419 Helios Technologies, Inc. (NASDAQ:HLIO) - MarketBeat
Hancock Whitney Corp Buys 10,920 Shares of PHINIA Inc. (NYSE:PHIN) - MarketBeat
PHINIA Inc. (NYSE:PHIN) Shares Acquired by Long Road Investment Counsel LLC - Defense World
King Luther Capital Management Corp Boosts Position in Helios Technologies, Inc. (NASDAQ:HLIO) - Defense World
Texas Permanent School Fund Corp Has $1.39 Million Stock Holdings in PHINIA Inc. (NYSE:PHIN) - Defense World
Thailand's new celebrity baby pygmy hippo, Moo Deng - The Business Standard
Bokf Na Has $58,000 Stock Position in Haleon plc (NYSE:HLN) - Defense World
American Century Companies Inc. Raises Position in PHINIA Inc. (NYSE:PHIN) - Defense World
Phio Pharmaceuticals Corp (PHIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.80%
0.42%
자본화:
|
볼륨(24시간):